| 摘要 |
<p>It is intended to provide a novel intestinal immunity activator that can activate intestinal immunity by distinguishing M cells in the Peyer's patch. According to the invention, the intestinal immunity activator comprising a compound represented by the following formula 1 is provided. Formula 1: TGDK-CH<SUB>2</SUB>-CH<SUB>2</SUB>-NH-R (In the formula, TGDK-CH<SUB>2</SUB>-CH<SUB>2</SUB>-NH represents a 2-[N-a,N-e-bis(N-a,N-e-digalloyllysinyl)lysinyl]aminoethylamino group, and R represents a hydrogen atom, a group having an active ester group via a peptide bond, a group bound to an SH group via a peptide bond, a peptide, a protein, a lipid or a sugar bound via a peptide bond or a peptide, a protein, a lipid or a sugar bound via a Schiff base.)</p> |
